Growth Metrics

Aura Biosciences (AURA) Other Working Capital Changes (2020 - 2026)

Aura Biosciences filings provide 7 years of Other Working Capital Changes readings, the most recent being -$386000.0 for Q1 2026.

  • Quarterly Other Working Capital Changes fell 18.77% to -$386000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$4.1 million through Mar 2026, up 15.85% year-over-year, with the annual reading at -$4.0 million for FY2025, 411.55% down from the prior year.
  • Other Working Capital Changes hit -$386000.0 in Q1 2026 for Aura Biosciences, up from -$3.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $4.0 million in Q3 2024 and bottomed at -$4.3 million in Q2 2024.
  • Average Other Working Capital Changes over 5 years is -$204625.0, with a median of -$345000.0 recorded in 2025.
  • Peak annual rise in Other Working Capital Changes hit 801.35% in 2024, while the deepest fall reached 864.56% in 2024.
  • Aura Biosciences' Other Working Capital Changes stood at $3.7 million in 2022, then plummeted by 135.31% to -$1.3 million in 2023, then plummeted by 222.52% to -$4.3 million in 2024, then rose by 29.32% to -$3.0 million in 2025, then skyrocketed by 87.2% to -$386000.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Other Working Capital Changes are -$386000.0 (Q1 2026), -$3.0 million (Q4 2025), and -$358000.0 (Q3 2025).